Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 403
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03582774 | Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy | ||
| NCT02925351 | Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases | ||
| NCT04285671 | Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer | ||
| NCT04915508 | Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy | ||
| NCT00427427 | Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer | ||
| NCT04407546 | Role of Children in Transmission of COVID-19 to Immunocompromised Patients | ||
| NCT01813877 | Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma | ||
| NCT00742729 | Increasing Colorectal Cancer Screening Among Filipino Americans | ||
| NCT02597894 | Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachytherapy | ||
| NCT00060294 | Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Waldenstrom's Macroglobulinemia | ||
| NCT00072072 | Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | ||
| NCT06980077 | Ivonescimab for the Treatment of Thymic Cancer | ||
| NCT00021281 | Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer | ||
| NCT01070186 | Study of Sunitinib in Subjects With High Risk Renal Cell Carcinoma | ||
| NCT06995053 | Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial | ||
| NCT00003225 | Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer | ||
| NCT07439484 | Individually Tailored, Supervised, Remote Exercise Intervention to Improve Physical Function for Stage I-III Gastroesophageal Cancer Survivors, PRECISE Trial | ||
| NCT02672033 | Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural Mesothelioma | ||
| NCT01525264 | Breast Cancer Screening Intervention | ||
| NCT01149850 | Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma | ||
| NCT04429204 | Cryoablation for the Promotion of Local Tumor Infiltration in Patients With Mesothelioma | ||
| NCT03503643 | Hemi-Gland Cryoablation for Prostate Cancer at UCLA | ||
| NCT00910650 | Study of Gene Modified Immune Cells in Patients With Advanced Melanoma | ||
| NCT01784640 | Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Cell Lung Cancer | ||
| NCT00798876 | Low-Fat Fish Oil Diet for Prostate Cancer Prevention | ||
| NCT03623854 | Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma | ||
| NCT02880020 | Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by Surgery | ||
| NCT00049322 | Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery | ||
| NCT04703101 | Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer | ||
| NCT00521209 | Patient-Directed Lifestyle Change and Health Promotion Program or Usual Care in Low-Income, Uninsured Participants in Los Angeles County, California | ||
| NCT06225011 | Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer | ||
| NCT04348682 | Expanded Access Protocol of 68Ga-PSMA-11 for PET Imaging | ||
| NCT04375527 | Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype Melanoma | ||
| NCT00023816 | Carbendazim in Treating Patients With Advanced Solid Tumors or Lymphoma | ||
| NCT02681328 | Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules | ||
| NCT00104767 | Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | ||
| NCT06432036 | Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial | ||
| NCT04069923 | OsteoCrete in Filling Bone Voids in Participants With Bone Voids or Defects | ||
| NCT00093769 | Bortezomib and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma | ||
| NCT05000359 | A Mobile Phone Intervention to Promote Adherence to Survivorship Care Among Adolescent and Young Adult Cancer Survivors | ||
| NCT03601455 | Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder Cancer | ||
| NCT00706615 | Vaccine Therapy in Treating Women With Previously Treated Metastatic Breast Cancer | ||
| NCT00003748 | Irinotecan in Treating Patients With Esophageal or Stomach Cancer | ||
| NCT07191717 | Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial | ||
| NCT04297020 | Brain Health in Breast Cancer Survivors | ||
| NCT00071968 | Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse | ||
| NCT03996850 | SPECT/CT for the Characterization of Renal Masses | ||
| NCT05045027 | Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma | ||
| NCT05457959 | Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutant | ||
| NCT03546361 | CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer |
